中医药调节巨噬细胞极化防治动脉粥样硬化易损斑块的研究进展
李小翠1 孟中华1 王贺2 尚莎莎2 王建茹2 关怀敏2 陈玉善2
1.河南中医药大学第一临床医学院,河南郑州 450000;
2.河南中医药大学第一附属医院心血管科三病区,河南郑州 450000
Research progress of Chinese medicine in the prevention and treatment of atherosclerotic vulnerable plaque by the regulation of macrophage polarization
LI Xiaocui1 MENG Zhonghua1 WANG He2 SHANG Shasha2 WANG Jianru2 GUAN Huaimin2 CHEN Yushan2
1.The First Clinical Medical College, He′nan University of Chinese Medicine, He′nan Province, Zhengzhou 450000, China;
2.Ward Three, Department of Cardiovascular Medicine, the First Affiliated Hospital of He′nan University of Chinese Medicine, He′nan Province, Zhengzhou 450000, China
摘要 动脉粥样硬化是冠心病的基本病理变化,易损斑块形成导致斑块稳定性下降、斑块破裂,是急性心血管事件的重要发病原因。巨噬细胞是动脉粥样硬化发生、发展过程中重要的炎症细胞,斑块的稳定性与巨噬细胞亚型的极化密切相关。中医药可通过调控巨噬细胞极化改善动脉粥样硬化斑块稳定性,在防治动脉粥样硬化易损斑块中展现良好的应用前景。本文以巨噬细胞极化为切入点,对中医药通过调控巨噬细胞极化影响动脉粥样硬化等方面进行论述。
关键词 :
中医药 ,
巨噬细胞极化 ,
动脉粥样硬化 ,
易损斑块
Abstract :Atherosclerosis is the basic pathological change of coronary heart disease. The formation of vulnerable plaque leads to decreased plaque stability and plaque rupture, which is an important etiology of acute cardiovascular events. Macrophages are important inflammatory cells during the initial and development of atherosclerosis. The stability of plaque is closely related to the polarization of macrophage subtypes. Chinese medicine have been revealed to improve the stability of atherosclerosis plaques by regulating the polarization of macrophages, and has a good application prospect in the prevention and treatment of atherosclerotic vulnerable plaques. This article takes macrophage polarization as the entry point, and discusses about Chinese medicine to affect atherosclerosis by regulating macrophage polarization.
Key words :
Chinese medicine
Macrophage polarization
Atherosclerosis
Vulnerable plaque
基金资助: 河南省科学攻关项目(182102310093);
河南省中医药科学研究专项课题(2019ZY1004)。
通讯作者:
陈玉善(1974.10-),女,主任医师,硕士生导师;研究方向:冠心病的基础与临床研究。
作者简介 : 李小翠(1989.10-),女,河南中医药大学第一临床医学院2017级心内科专业在读硕士研究生;研究方向:冠心病的基础与临床研究。
引用本文:
李小翠1 孟中华1 王贺2 尚莎莎2 王建茹2 关怀敏2 陈玉善2. 中医药调节巨噬细胞极化防治动脉粥样硬化易损斑块的研究进展[J]. 中国医药导报, 2020, 17(13): 58-61.
LI Xiaocui1 MENG Zhonghua1 WANG He2 SHANG Shasha2 WANG Jianru2 GUAN Huaimin2 CHEN Yushan2. Research progress of Chinese medicine in the prevention and treatment of atherosclerotic vulnerable plaque by the regulation of macrophage polarization. 中国医药导报, 2020, 17(13): 58-61.
链接本文:
http://www.yiyaodaobao.com.cn/CN/ 或 http://www.yiyaodaobao.com.cn/CN/Y2020/V17/I13/58
[1] Shapouri-Moghaddam A,Mohammadian S,Vazini H,et al. Macrophage plasticity,polarization,and function in health and disease [J]. J Cell Physiol,2018,233(9):6425-6440.
[2] 张平.STEMI直接经PCI支架内血栓形成的发生率、危险因素及对预后的影响[J].世界最新医学信息文摘,2016, 16(57):66,69.
[3] 赵燕,张毅刚,王海波,等.STEMI患者入院后急性期内NLR数值与院内 MACE发生率的相关性[J].岭南心血管病杂志,2017,23(2):133-137.
[4] Chen B,Ni Y,Liu J,et al. Bone marrow-derived mesenchymal stem cells exert diverse effects on different macrophage subsets [J]. Stem Cells Int,2018,2018:8348121.
[5] Mosig S,Rennert K,Krause S,et al. Different functions of monocyte subsets in familial hypercholesterolemia:potential function of CD14+CD16+ monocytes in detoxification of oxidized LDL [J]. FASEB J,2009,23(3):866-874.
[6] Juhas U,Ryba-stanis?覥awowska M,Szargiej P,et al. Different pathways of macrophage activation and polarization [J]. Postepy Hig Med Dosw(Online),2015,69:496-502.
[7] Mury P,Chirico EN,Mura M,et al. Oxidative stress and inflammation,key targets of atherosclerotic plaque progression and vulnerability:potential impact of physical activity [J]. Sports Med,2018,48(12):2725-2741.
[8] 李涯南.基质金属蛋白酶-2(MMP-2)、基质金属蛋白酶-9(MMP-9)对人颈内动脉粥样硬化斑块稳定性影响的研究[D].石家庄:河北医科大学,2016.
[9] Yabluchanskiy A,Ma Y,Deleon-Pennell KY,et al. Myocardial infarction superimposed on aging:MMP-9 deletion promotes M2 macrophage polarization [J]. J Gerontol A Biol Sci Med Sci,2016,71(4):475-483.
[10] Woollard KJ,Geissmann F. Monocytes in atherosclerosis:subsets and functions [J]. Nat Rev Cardiol,2010,7(2):77-86.
[11] Leroyer AS,Isobe H,Lesèche G,et al. Cellular origins and thrombogenic activity of microparticles isolated from human atherosclerotic plaques [J]. J Am Coll Cardiol,2007, 49(7):772-777.
[12] Costantini A,Viola N,Berretta A,et al. Age-related M1/M2 phenotype changes in circulating monocytes from healthy/unhealthy individuals [J]. Aging,2018,10(6):1268-1280.
[13] 盘德辉,梁健球.冠心病患者血清IL-17A水平变化及与冠状动脉狭窄程度和超敏C反应蛋白的关系[J].广东医学,2017,38(13):2027-2030.
[14] 边宁,龚博君,郭军,等.一氧化氮/诱导型一氧化氮合酶在动脉粥样硬化过程中的作用[J].中国病理生理杂志,2014,30(3):414-418.
[15] 吴艾霖,熊怡淞.冠心病患者血浆相关细胞因子检测及临床意义[J].国际检验医学杂志,2013,34(5):536-538.
[16] Philipp D,Suhr L,Wahlers T,et al. Preconditioning of bone marrow-derived mesenchymal stem cells highly strengthens their potential to promote IL-6-dependent M2b polarization [J]. Stem Cell Res Ther,2018,9(1): 286.
[17] 耿红莲,仲人前.巨噬细胞在动脉粥样硬化中的作用[J].国际检验医学杂志,2014,35(11):1451-1453.
[18] 陈金艳,田翔宇,贺璐璐,等.M2型巨噬细胞向M1型巨噬细胞的转化及其意义[J].中华实验外科杂志,2016, 33(4):953-955.
[19] Stoger JL,Gijbels MJ,van der Velden S,et al. Distribution of macrophage polarization markers in human ather-osclerosis [J]. Atherosclerosis,2012,225(2):461-468.
[20] 周光妍,于波.冠状动脉易损斑块形成机制研究进展[J].中华老年多器官疾病杂志,2018,17(2):153-155.
[21] Cuchel M,Raper AC,Conlon DM,et al. A novel approach to measuring macrophage-specific reverse cholesterol transport in vivo in humans [J]. J Lipid Res,2017, 58(4):752-762.
[22] 邓凌志.冠心病患者外周血M2巨噬细胞水平变化及其极化的相关信号通路[D].衡阳:南华大学,2016.
[23] Sica A,Erreni M,Allavena P,et al. Macrophage polarization in pathology [J]. Cell Mol Life Sci,2015,72(21):4111-4126.
[24] 蒋跃绒,谢元华,张京春,等.陈可冀治疗心血管疾病血瘀证用药规律数据挖掘[J].中医杂志,2015,56(5):376-380.
[25] 于红红,吴玛莉,张智伟,等.黄连解毒汤含药血清对脂多糖诱导的巨噬细胞炎症因子影响研究[J].亚太传统医药,2016,12(14):11-13.
[26] 李彤,韩俊燕,王蓓蓓,等.黄连解毒汤调控单核、巨噬细胞及泡沫细胞分化的实验研究[J].中国中西医结合杂志,2014,34(9):1096-1102.
[27] 田维毅.基于M1/M2型Mφ极化及炎症调控效应探索黄连解毒汤干预AS的作用与机制[D].长沙:湖南中医药大学,2015.
[28] 郭会敏.小檗碱抗动脉粥样硬化机制的研究进展[J].心血管病学进展,2018,39(1):72-75.
[29] 万强,周凤华,崔小冰,等.小檗碱通过JNK通路降低内脏脂肪素诱导人脐静脉内皮细胞分泌IL-6和TNF-α的研究[J].中草药,2015,46(7):1012-1017.
[30] Yu Y,Zhang M,Hu Y,et al. Increased bioavailable berberine protects against myocardial ischemia reperfusion injury through attenuation of NF-κB and JNK signaling pathways [J]. Int Heart J,2018,59(6):1378-1388.
[31] Du J,Ding X,Zhang X,et al. Berberine attenuate staphylococcal enterotoxin B-mediated acute liver injury via regulating HDAC expression [J]. AMB Express,2018,8(1):158.
[32] 袁静静,王贺,司春婴,等.姜黄素抗动脉粥样硬化作用研究进展[J].光明中医,2018,33(12):1829-1830.
[33] Liu Z,Ran Y,Huang S,et al. Curcumin protects against ischemic stroke by titrating microglia/macrophage polarization [J]. Front Aging Neurosci,2017,9:233.
[34] Pan Y,Zhao D,Yu N,et al. Curcumin improves glycolipid metabolism through regulating peroxisome proliferator activated receptor γ signaling pathway in high-fat diet-induced obese mice and 3T3-L1 adipocytes [J]. R Soc Open Sci,2017,4(11):170917.
[35] Gao S,Zhou J,Liu N,et al. Curcumin induces M2 macrophage polarization by secretion IL-4 and/or IL-13 [J]. J Mol Cell Cardiol,2015,85:131-139.
[1]
张欢 孙劲晖. 基于肠道微生态探索“调肝理脾”法治疗酒精性肝病的新思路 [J]. 中国医药导报, 2020, 17(9): 123-126.
[2]
张媛 欧阳静. 媒介融合背景下中医药健康文化传播生态研究 [J]. 中国医药导报, 2020, 17(9): 164-167.
[3]
张斐斐 陈锋 刘平. 跨文化视阈下中医药新媒体视觉化传播研究 [J]. 中国医药导报, 2020, 17(9): 188-191,196.
[4]
高恋丽1 许伟明2 林亭秀1 吴芳1 胡春宇1 宋春生1 马晓北1. 中医药博士生学术英语教学大纲设置要素的实证研究 [J]. 中国医药导报, 2020, 17(8): 52-55.
[5]
张佳慧1,2 王笑民2▲ 杨永2 于明薇2. 王笑民教授从“毒”论治肿瘤经验 [J]. 中国医药导报, 2020, 17(8): 190-193.
[6]
刘兴慈1 苏克雷2 张业清1,2 朱梦月1 刘茜1 曹亚坤1 何孔琴1. 基于肠道微生态角度探讨中医药治疗社区获得性肺炎的作用机制 [J]. 中国医药导报, 2020, 17(7): 39-42.
[7]
付金香1 祁烁2 陈晓珩2 李会龙2 黄盛1 李心爱1 张磊1 丁治国2. 丁治国教授治疗桥本甲状腺炎合并甲状腺结节案例一则 [J]. 中国医药导报, 2020, 17(7): 120-123.
[8]
侯春艳1 谭娟1 张文江2 杨泽1. 双心护理结合揿针对冠状动脉粥样硬化性心脏病患者心理痛苦的影响 [J]. 中国医药导报, 2020, 17(7): 185-188.
[9]
吕凯峰 张伟 陈宏. 中医药治疗小儿肺炎临床研究进展 [J]. 中国医药导报, 2020, 17(6): 37-39.
[10]
王玮娇 张洪雷. 中医药文化产业特点、现状与发展路径辨析 [J]. 中国医药导报, 2020, 17(6): 140-143,148.
[11]
沈玮玮 王靖宇 柯飞 孙婉钧 周良荣. 协同治理视阈下中医药健康扶贫之路径研究 [J]. 中国医药导报, 2020, 17(6): 181-184.
[12]
李秀明1 张晶1 韩桂香2. 新时代自主创新背景下中医药文化传承与知识产权保护路径探析 [J]. 中国医药导报, 2020, 17(5): 152-155.
[13]
赵元辰 刘世刚. 肺部结节的中西医诊治探讨 [J]. 中国医药导报, 2020, 17(5): 192-196.
[14]
杨卯勤1 薛敬东2 李粉萍2 董璐2 傅琪琳2. 中医无饥饿禁食疗法对非酒精性脂肪肝患者糖脂代谢和肝脏脂肪沉积的影响 [J]. 中国医药导报, 2020, 17(4): 135-138.
[15]
刘璐 聂海洋. 中医药地理标志产品的保护与发展探讨 [J]. 中国医药导报, 2020, 17(4): 139-142,154.